Lupus patients to benefit from RituximabA drug presently used for treating cancer patients could be used to treat patients with lupus and suffering from complications of the central nervous system, as per rheumatologists at the Annual European Congress of Rheumatology in Vienna, Austria.

The drug, Rituximab, is effective to provide relief to patients afflicted with lupus and could be considered as a gentle form of treatment that can last up to a period of six months with little to no side effects, according to Clinical professor Michael Neuwelt, at the University of California San Francisco and Stanford University.

Lupus is a health complication characterized by reduced quality of life and symptoms such as pain, inflammation, and diffused damage to many body organs.